{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:53:33Z","timestamp":1791910413542,"version":"4.3.4"},"reference-count":121,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T00:00:00Z","timestamp":1627689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32HL069749-17"],"award-info":[{"award-number":["5T32HL069749-17"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08HL135275"],"award-info":[{"award-number":["K08HL135275"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23HL151744"],"award-info":[{"award-number":["K23HL151744"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["20IPA35310955"],"award-info":[{"award-number":["20IPA35310955"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jacbts.2021.07.010","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T15:26:57Z","timestamp":1637594817000},"page":"918-932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["Relationship of Nonalcoholic Fatty Liver Disease and Heart\u00a0Failure With Preserved Ejection Fraction"],"prefix":"10.1016","volume":"6","author":[{"given":"Husam M.","family":"Salah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambarish","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anzhela","family":"Soloveva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal F.","family":"Abdelmalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Mae","family":"Diehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Moylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Wegermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal N.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian F.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Tedford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishan S.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Mentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"McGarrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marat","family":"Fudim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacbts.2021.07.010_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacbts.2021.07.010_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","article-title":"Global public health burden of heart failure","volume":"3","author":"Savarese","year":"2017","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.jacbts.2021.07.010_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/heartasia-2011-010023","article-title":"Liver diseases in heart failure","volume":"3","author":"Maleki","year":"2011","journal-title":"Heart Asia"},{"key":"10.1016\/j.jacbts.2021.07.010_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.30699\/ijp.2017.25038","article-title":"Clinical manifestations and diagnosis of nonalcoholic fatty liver disease","volume":"12","author":"Khoonsari","year":"2017","journal-title":"Iran J Pathol"},{"key":"10.1016\/j.jacbts.2021.07.010_bib5","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2021.07.010_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/oby.21901","article-title":"Is fatty liver a risk marker for heart failure?","volume":"25","author":"VanWagner","year":"2017","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jacbts.2021.07.010_bib7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/10408363.2011.596521","article-title":"Non-alcoholic fatty liver disease","volume":"48","author":"Smith","year":"2011","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.jacbts.2021.07.010_bib8","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhep.2008.06.018","article-title":"Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease","volume":"49","author":"Ong","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacbts.2021.07.010_bib9","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.3390\/ijerph16173104","article-title":"Cardiovascular risk in non-alcoholic fatty liver disease: mechanisms and therapeutic implications","volume":"16","author":"Tana","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jacbts.2021.07.010_bib10","first-page":"457","article-title":"Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease","volume":"17","author":"Fotbolcu","year":"2010","journal-title":"Cardiol J"},{"key":"10.1016\/j.jacbts.2021.07.010_bib11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MEG.0000000000000008","article-title":"Impaired left ventricular mechanics in nonalcoholic fatty liver disease: a speckle-tracking echocardiography study","volume":"26","author":"Karabay","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jacbts.2021.07.010_bib12","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/hep.27869","article-title":"Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study","volume":"62","author":"VanWagner","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jacbts.2021.07.010_bib13","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/oby.21879","article-title":"Nonalcoholic steatohepatitis is associated with cardiac remodeling and dysfunction","volume":"25","author":"Simon","year":"2017","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jacbts.2021.07.010_bib14","first-page":"3959","article-title":"Chronic heart failure in patients with nonalcoholic fatty liver disease: prevalence, clinical features, and relevance","volume":"46","author":"Zhang","year":"2018","journal-title":"J\u00a0Int Med Res"},{"key":"10.1016\/j.jacbts.2021.07.010_bib15","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00380-017-1113-1","article-title":"The impact of non-alcoholic fatty liver disease fibrosis score on cardiac prognosis in patients with chronic heart failure","volume":"33","author":"Takahashi","year":"2018","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jacbts.2021.07.010_bib16","doi-asserted-by":"crossref","first-page":"12440","DOI":"10.1038\/s41598-020-69013-y","article-title":"Prevalence and staging of non-alcoholic fatty liver disease among patients with heart failure with preserved ejection fraction","volume":"10","author":"Miller","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.jacbts.2021.07.010_bib17","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/ehf2.13250","article-title":"Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT","volume":"8","author":"Peters","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacbts.2021.07.010_bib18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ehf2.12222","article-title":"Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction","volume":"5","author":"Yoshihisa","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacbts.2021.07.010_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007308","article-title":"Extracardiac abnormalities of preload reserve: mechanisms underlying exercise limitation in heart failure with preserved ejection fraction, autonomic dysfunction, and liver disease","volume":"14","author":"Fudim","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2021.07.010_bib20","article-title":"Longitudinal association of non-alcoholic fatty liver disease with changes in myocardial structure and function: the CARDIA study","volume":"9","author":"VanWagner","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2021.07.010_bib21","article-title":"Cardiac morphology, function, and hemodynamics in patients with morbid obesity and nonalcoholic steatohepatitis","volume":"10","author":"Styczynski","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2021.07.010_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","article-title":"Phenomapping for novel classification of heart failure with preserved ejection fraction","volume":"131","author":"Shah","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.07.010_bib23","first-page":"172","article-title":"Clinical phenogroups in heart failure with preserved ejection fraction","volume":"8","author":"Cohen","year":"2020","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacbts.2021.07.010_bib24","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1148\/radiol.14132952","article-title":"Nonalcoholic fatty liver disease: portal hypertension due to outflow block in patients without cirrhosis","volume":"274","author":"Hirooka","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.jacbts.2021.07.010_bib25","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1053\/gast.1996.v111.pm8898644","article-title":"Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension","volume":"111","author":"Garc\u00eda-Pag\u00e0n","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacbts.2021.07.010_bib26","first-page":"1376","article-title":"Aerobic capacity and exercise performance in nonalcoholic fatty liver disease","volume":"59","author":"Austin","year":"2019","journal-title":"J\u00a0Sports Med Phys Fitness"},{"key":"10.1016\/j.jacbts.2021.07.010_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152512","article-title":"Differential sympathetic vasomotor activation induced by liver cirrhosis in rats","volume":"11","author":"Estrela","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jacbts.2021.07.010_bib28","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.metabol.2016.02.001","article-title":"Computerized tomography measured liver fat is associated with low levels of N-terminal pro-brain natriuretic protein (NT-proBNP). Multi-Ethnic Study of Atherosclerosis","volume":"65","author":"Sanchez","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.jacbts.2021.07.010_bib29","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.numecd.2020.05.017","article-title":"Lower levels of plasma NT-proBNP are associated with higher prevalence of NASH in patients with biopsy-proven NAFLD","volume":"30","author":"Qiao","year":"2020","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jacbts.2021.07.010_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cca.2019.06.019","article-title":"Metabolic syndrome is an inflammatory disorder: a conspiracy between adipose tissue and phagocytes","volume":"496","author":"Reddy","year":"2019","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacbts.2021.07.010_bib31","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacbts.2021.07.010_bib32","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications","volume":"65","author":"Francque","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacbts.2021.07.010_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230657","article-title":"Associations of inflammatory markers with impaired left ventricular diastolic and systolic function in collagen-induced arthritis","volume":"15","author":"Mokotedi","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jacbts.2021.07.010_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5603\/KP.a2018.0214","article-title":"Inflammatory markers and left ventricular diastolic dysfunction in a family-based population study","volume":"77","author":"Kloch","year":"2019","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.jacbts.2021.07.010_bib35","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10741-010-9158-6","article-title":"Role of osteopontin in heart failure associated with aging","volume":"15","author":"Singh","year":"2010","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacbts.2021.07.010_bib36","doi-asserted-by":"crossref","first-page":"154837","DOI":"10.1016\/j.cyto.2019.154837","article-title":"Increased plasma osteopontin levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus","volume":"125","author":"Wang","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.jacbts.2021.07.010_bib37","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.aohep.2020.01.001","article-title":"Osteopontin\u2014a potential biomarker of advanced liver disease","volume":"19","author":"Bruha","year":"2020","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jacbts.2021.07.010_bib38","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1080\/14756366.2019.1587418","article-title":"Osteopontin\u2014a biomarker of disease, but also of stage stratification of the functional myocardial contractile deficit by chronic ischaemic heart disease","volume":"34","author":"Coculescu","year":"2019","journal-title":"J\u00a0Enzyme Inhib Med Chem"},{"key":"10.1016\/j.jacbts.2021.07.010_bib39","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.metabol.2010.07.027","article-title":"Plasma levels of asymmetric dimethylarginine in patients with biopsy-proven nonalcoholic fatty liver disease","volume":"60","author":"Kasumov","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.jacbts.2021.07.010_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136822","article-title":"Dysregulated hepatic methionine metabolism drives homocysteine elevation in diet-induced nonalcoholic fatty liver disease","volume":"10","author":"Pacana","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jacbts.2021.07.010_bib41","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jacc.2018.11.050","article-title":"Nonalcoholic fatty liver disease and the heart: JACC state-of-the-art review","volume":"73","author":"Stahl","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2021.07.010_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1259\/bjr\/38447238","article-title":"The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis","volume":"85","author":"Shuster","year":"2012","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jacbts.2021.07.010_bib43","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fcvm.2019.00110","article-title":"Heart failure with preserved ejection fraction and adipose tissue: a story of two tales","volume":"6","author":"Oh","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacbts.2021.07.010_bib44","first-page":"999","article-title":"Adiposity and incident heart failure and its subtypes: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"6","author":"Rao","year":"2018","journal-title":"J\u00a0Am Coll Cardiol HF"},{"issue":"suppl 2","key":"10.1016\/j.jacbts.2021.07.010_bib45","doi-asserted-by":"crossref","first-page":"S367","DOI":"10.2337\/dc11-s249","article-title":"Lipids in the wrong place: visceral fat and nonalcoholic steatohepatitis","volume":"34","author":"Perseghin","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacbts.2021.07.010_bib46","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/ejhf.1956","article-title":"Regional adiposity and heart failure with preserved ejection fraction","volume":"22","author":"Rao","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2021.07.010_bib47","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/oby.2003.45","article-title":"Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction","volume":"11","author":"Iacobellis","year":"2003","journal-title":"Obes Res"},{"key":"10.1016\/j.jacbts.2021.07.010_bib48","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1161\/01.CIR.0000099542.57313.C5","article-title":"Human epicardial adipose tissue is a source of inflammatory mediators","volume":"108","author":"Mazurek","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.07.010_bib49","first-page":"657","article-title":"Hemodynamic and functional impact of epicardial adipose tissue in heart failure with preserved ejection fraction","volume":"8","author":"Koepp","year":"2020","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacbts.2021.07.010_bib50","doi-asserted-by":"crossref","first-page":"E282","DOI":"10.1152\/ajpendo.00604.2005","article-title":"Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes","volume":"291","author":"Lautam\u00e4ki","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jacbts.2021.07.010_bib51","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jacc.2010.02.049","article-title":"Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes","volume":"56","author":"Rijzewijk","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2021.07.010_bib52","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/hep.21983","article-title":"Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver","volume":"47","author":"Perseghin","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jacbts.2021.07.010_bib53","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1126\/science.aav0558","article-title":"Branched-chain amino acids in disease","volume":"363","author":"White","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jacbts.2021.07.010_bib54","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00726-014-1894-9","article-title":"Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease","volume":"47","author":"Lake","year":"2015","journal-title":"Amino Acids"},{"key":"10.1016\/j.jacbts.2021.07.010_bib55","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41591-018-0061-3","article-title":"Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women","volume":"24","author":"Hoyles","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jacbts.2021.07.010_bib56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hep.29465","article-title":"Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance","volume":"67","author":"Gaggini","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jacbts.2021.07.010_bib57","doi-asserted-by":"crossref","first-page":"dgaa175","DOI":"10.1210\/clinem\/dgaa175","article-title":"Plasma BCAA changes in patients with NAFLD are sex dependent","volume":"105","author":"Grzych","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacbts.2021.07.010_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204308","article-title":"Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: a pilot study","volume":"13","author":"Wegermann","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jacbts.2021.07.010_bib59","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.cmet.2018.04.015","article-title":"The BCKDH kinase and phosphatase integrate BCAA and lipid metabolism via regulation of ATP-citrate lyase","volume":"27","author":"White","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.jacbts.2021.07.010_bib60","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.molmet.2016.04.006","article-title":"Branched-chain amino acid restriction in Zucker-fatty rats improves muscle insulin sensitivity by enhancing efficiency of fatty acid oxidation and acyl-glycine export","volume":"5","author":"White","year":"2016","journal-title":"Mol Metab"},{"key":"10.1016\/j.jacbts.2021.07.010_bib61","doi-asserted-by":"crossref","first-page":"E216","DOI":"10.1152\/ajpendo.00334.2019","article-title":"Dietary branched-chain amino acid restriction alters fuel selection and reduces triglyceride stores in hearts of Zucker fatty rats","volume":"318","author":"McGarrah","year":"2020","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jacbts.2021.07.010_bib62","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/s41467-021-21962-2","article-title":"Branched-chain \u03b1-ketoacids are preferentially reaminated and activate protein synthesis in the heart","volume":"12","author":"Walejko","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacbts.2021.07.010_bib63","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.3748\/wjg.v26.i15.1726","article-title":"Spontaneous porto-systemic shunts in liver cirrhosis: clinical and therapeutical aspects","volume":"26","author":"Nardelli","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jacbts.2021.07.010_bib64","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/CRD.0000000000000195","article-title":"Diagnosis, treatment, and management of orthotopic liver transplant candidates with portopulmonary hypertension","volume":"26","author":"Koulava","year":"2018","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.jacbts.2021.07.010_bib65","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/01.CIR.102.14.1718","article-title":"Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management","volume":"102","author":"Moraes","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.07.010_bib66","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jacc.2008.11.051","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study","volume":"53","author":"Lam","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2021.07.010_bib67","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/0016-5085(93)90285-K","article-title":"Arteriovenous shunting, hemodynamic changes, and renal sodium retention in liver cirrhosis","volume":"104","author":"Fernandez-Rodriguez","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacbts.2021.07.010_bib68","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s12072-013-9469-5","article-title":"Left atrial function is impaired in cirrhosis: a speckle tracking echocardiographic study","volume":"8","author":"Sampaio","year":"2014","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jacbts.2021.07.010_bib69","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1093\/eurheartj\/ehx045","article-title":"Long-term cardiovascular changes following creation of arteriovenous fistula in patients with end stage renal disease","volume":"38","author":"Reddy","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2021.07.010_bib70","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11897-013-0155-7","article-title":"The emerging epidemic of heart failure with preserved ejection fraction","volume":"10","author":"Oktay","year":"2013","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.jacbts.2021.07.010_bib71","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12072-014-9531-y","article-title":"Cirrhotic cardiomyopathy: review of pathophysiology and treatment","volume":"8","author":"Chayanupatkul","year":"2014","journal-title":"Hepatol Int"},{"issue":"5","key":"10.1016\/j.jacbts.2021.07.010_bib72","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/liv.14769","article-title":"The prevalence of cirrhotic cardiomyopathy according to different diagnostic criteria","volume":"41","author":"Razpotnik","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jacbts.2021.07.010_bib73","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.30875","article-title":"Redefining cirrhotic cardiomyopathy for the modern era","volume":"71","author":"Izzy","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jacbts.2021.07.010_bib74","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/heart.87.1.9","article-title":"Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease","volume":"87","author":"Moller","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.jacbts.2021.07.010_bib75","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/gut.49.2.268","article-title":"The cardiac response to exercise in cirrhosis","volume":"49","author":"Wong","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jacbts.2021.07.010_bib76","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1023\/A:1018867232562","article-title":"Analysis of impaired exercise capacity in patients with cirrhosis","volume":"43","author":"Epstein","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jacbts.2021.07.010_bib77","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0168-8278(95)80286-X","article-title":"Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis","volume":"22","author":"Grose","year":"1995","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacbts.2021.07.010_bib78","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0168-8278(91)90940-D","article-title":"Reduced cardiovascular responsiveness to exercise-induced sympathoadrenergic stimulation in patients with cirrhosis","volume":"12","author":"Bernardi","year":"1991","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacbts.2021.07.010_bib79","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cld.573","article-title":"Congestive hepatopathy","volume":"8","author":"Hilscher","year":"2016","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.jacbts.2021.07.010_bib80","first-page":"87","article-title":"Heart failure and liver disease: cardiohepatic interactions","volume":"7","author":"Xanthopoulos","year":"2019","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacbts.2021.07.010_bib81","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2169\/internalmedicine.46.0059","article-title":"Hypoxic hepatopathy: pathophysiology and prognosis","volume":"46","author":"Birrer","year":"2007","journal-title":"Intern Med"},{"key":"10.1016\/j.jacbts.2021.07.010_bib82","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1093\/eurheartj\/eht246","article-title":"Interactions of the heart and the liver","volume":"34","author":"Moller","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2021.07.010_bib83","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jacc.2021.04.090","article-title":"Lymphatic dysregulation in patients with heart failure","volume":"78","author":"Fudim","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2021.07.010_bib84","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0002-9149(03)00370-9","article-title":"Liver dysfunction and heart failure","volume":"91","author":"Cogger","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacbts.2021.07.010_bib85","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ijcard.2012.05.003","article-title":"Congestive hepatopathy and hypoxic hepatitis in heart failure: a cardiologist\u2019s point of view","volume":"166","author":"Kavoliuniene","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacbts.2021.07.010_bib86","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2362.2011.02573.x","article-title":"Liver dysfunction in chronic heart failure: prevalence, characteristics and prognostic significance","volume":"42","author":"Poelzl","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jacbts.2021.07.010_bib87","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/eurjhf\/hfs007","article-title":"Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial","volume":"14","author":"Ambrosy","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2021.07.010_bib88","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4103\/2230-8210.163172","article-title":"Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes","volume":"19","author":"Sanyal","year":"2015","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.jacbts.2021.07.010_bib89","doi-asserted-by":"crossref","first-page":"18541","DOI":"10.1038\/s41598-019-55116-8","article-title":"Serum levels of gamma-glutamyltransferase predict outcome in heart failure with preserved ejection fraction","volume":"9","author":"Dalos","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2021.07.010_bib90","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.gtc.2011.06.010","article-title":"Noninvasive tools to assess hepatic fibrosis: ready for prime time?","volume":"40","author":"Schmeltzer","year":"2011","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jacbts.2021.07.010_bib91","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1253\/circj.CJ-15-1200","article-title":"Value of virtual touch quantification elastography for assessing liver congestion in patients with heart failure","volume":"80","author":"Yoshitani","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.jacbts.2021.07.010_bib92","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cardfail.2019.01.020","article-title":"Relationship of liver stiffness with congestion in patients presenting with acute decompensated heart failure","volume":"25","author":"Soloveva","year":"2019","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacbts.2021.07.010_bib93","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jacbts.2021.07.010_bib94","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2021.07.010_bib95","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2021.07.010_bib96","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ahj.2020.10.064","article-title":"Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes\u2014systematic review and meta-analysis of randomized placebo-controlled trials","volume":"232","author":"Salah","year":"2021","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacbts.2021.07.010_bib97","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ahj.2020.12.007","article-title":"Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: a meta-analysis update","volume":"233","author":"Salah","year":"2021","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacbts.2021.07.010_bib98","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2030183","article-title":"Sotagliflozin in patients with diabetes and recent worsening heart failure","volume":"384","author":"Bhatt","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2021.07.010_bib99","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/jdi.13237","article-title":"Effects of sodium-glucose cotransporter 2 inhibitors on non-alcoholic fatty liver disease in patients with type 2 diabetes: a meta-analysis of randomized controlled trials","volume":"11","author":"Xing","year":"2020","journal-title":"J\u00a0Diabetes Investig"},{"key":"10.1016\/j.jacbts.2021.07.010_bib100","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12265-018-9795-z","article-title":"GLP-1 improves diastolic function and survival in heart failure with preserved ejection fraction","volume":"11","author":"Nguyen","year":"2018","journal-title":"J\u00a0Cardiovasc Transl Res"},{"key":"10.1016\/j.jacbts.2021.07.010_bib101","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12933-019-0857-6","article-title":"Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial","volume":"18","author":"Bizino","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacbts.2021.07.010_bib102","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacbts.2021.07.010_bib103","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A\u00a0placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2021.07.010_bib104","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2021.07.010_bib105","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/oby.2007.114","article-title":"ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats","volume":"16","author":"Toblli","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jacbts.2021.07.010_bib106","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1038\/s41598-021-81959-1","article-title":"Clinical implications of renin\u2013angiotensin system inhibitors for development and progression of non-alcoholic fatty liver disease","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2021.07.010_bib107","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s40814-018-0306-4","article-title":"A\u00a0randomized, controlled, crossover pilot study of losartan for pediatric nonalcoholic fatty liver disease","volume":"4","author":"Vos","year":"2018","journal-title":"Pilot Feasibility Stud"},{"key":"10.1016\/j.jacbts.2021.07.010_bib108","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/0192623318778508","article-title":"Spironolactone in Combination with \u03b1-glycosyl isoquercitrin prevents steatosis-related early hepatocarcinogenesis in rats through the observed NADPH oxidase modulation","volume":"46","author":"Murayama","year":"2018","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.jacbts.2021.07.010_bib109","doi-asserted-by":"crossref","first-page":"E1415","DOI":"10.1152\/ajpendo.00419.2013","article-title":"Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet","volume":"305","author":"Wada","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jacbts.2021.07.010_bib110","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/1753944716642677","article-title":"Cardiac remodelling and RAS inhibition","volume":"10","author":"Ferrario","year":"2016","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.jacbts.2021.07.010_bib111","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2021.07.010_bib112","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.amjcard.2021.01.013","article-title":"Meta-analysis of efficacy of sacubitril\/valsartan in heart failure with preserved ejection fraction","volume":"145","author":"Salah","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacbts.2021.07.010_bib113","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.7150\/ijms.49373","article-title":"Angiotensin II receptor neprilysin inhibitor (LCZ696) compared to valsartan attenuates hepatotoxicity in STZ-induced hyperglycemic rats","volume":"17","author":"Alqahtani","year":"2020","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.jacbts.2021.07.010_bib114","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/ejhf.1853","article-title":"Liver function and prognosis, and influence of sacubitril\/valsartan in patients with heart failure with reduced ejection fraction","volume":"22","author":"Suzuki","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2021.07.010_bib115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ejhf.1369","article-title":"The use of diuretics in heart failure with congestion\u2014a position statement from the Heart\u00a0Failure Association of the European Society of Cardiology","volume":"21","author":"Mullens","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2021.07.010_bib116","first-page":"561","article-title":"Effect of weight loss on magnetic resonance imaging estimation of liver fat and volume in patients with nonalcoholic steatohepatitis","volume":"13","author":"Patel","year":"2015","journal-title":"Clin\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jacbts.2021.07.010_bib117","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/hep.28392","article-title":"Diet, weight loss, and liver health in nonalcoholic fatty liver disease: pathophysiology, evidence, and practice","volume":"63","author":"Marchesini","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jacbts.2021.07.010_bib118","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/oby.22038","article-title":"Bariatric surgery-induced cardiac and lipidomic changes in obesity-related heart failure with preserved ejection fraction","volume":"26","author":"Mikhalkova","year":"2018","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jacbts.2021.07.010_bib119","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4254\/wjh.v11.i2.138","article-title":"Bariatric surgery in patients with non-alcoholic fatty liver disease\u2014from pathophysiology to clinical effects","volume":"11","author":"Laursen","year":"2019","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jacbts.2021.07.010_bib120","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1053\/j.gastro.2020.06.006","article-title":"Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis","volume":"159","author":"Lassailly","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacbts.2021.07.010_bib121","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.cgh.2018.10.017","article-title":"Complete resolution of nonalcoholic fatty liver disease after bariatric surgery: a systematic review and meta-analysis","volume":"17","author":"Lee","year":"2019","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X21002606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X21002606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:24:45Z","timestamp":1762820685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X21002606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":121,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2452302X21002606"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2021.07.010","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship of Nonalcoholic Fatty Liver Disease and Heart\u00a0Failure With Preserved Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2021.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}